Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

ABBOTINDIA's revenue projections indicate a decrease from the prior year, which may make investors hesitant. A revenue decline could harm the company's bottom line, prompting investors to be more careful, as lower earnings often signal potential issues with profitability and future performance.

Financial Ratios:

currentRatio 3.38600
forwardPE 35.81158
debtToEquity 4.64600
earningsGrowth 0.27900
revenueGrowth 0.11500
grossMargins 0.42622
operatingMargins 0.25590
trailingEps 666.09000
forwardEps 0.00000

A current ratio of 3.386 for ABBOTINDIA implies that the company has ample liquidity to meet its short-term debts. ABBOTINDIA's cash reserves and current assets should easily cover these obligations, highlighting its financial stability and ability to manage short-term liabilities.
ABBOTINDIA's positive earnings and revenue growth reflect an optimistic outlook for the company's future. The growth in these key areas indicates that ABBOTINDIA is expected to continue expanding its business and boosting its financial performance in the coming periods.
ABBOTINDIA's positive gross and operating margins reflect its ability to generate profits from operations. These margins demonstrate efficient cost control and profitability, indicating strong financial health for the company.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

Over time, price projections for ABBOTINDIA have been gradually revised upward, reflecting increasing optimism about the company's future performance. This trend suggests analysts are growing more confident in ABBOTINDIA's ability to deliver strong results and achieve higher market value.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


The recent buy bias for ABBOTINDIA from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see ABBOTINDIA as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.